Antisense Therapeutics Ltd - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring industry group for Antisense Therapeutics Ltd are shown below. The webpage displays a zero-cost ESG analysis for Antisense Therapeutics Ltd. The Disclosure score covers 17 UN SDGs including: 'Gender Equality', 'Reduced Inequalities' and 'Life below Water'.
Antisense Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 5.3, social score of 4.8 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
| 483 | aTyr Pharma Inc | 6.1 | High |
| 498 | Antisense Therapeutics Ltd | 6.0 | High |
| 498 | Cann Group Ltd | 6.0 | High |
| 498 | Biosynex SA | 6.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Antisense Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Antisense Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Antisense Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Antisense Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Antisense Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Antisense Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Antisense Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Antisense Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Antisense Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Antisense Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Antisense Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Antisense Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Antisense Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Antisense Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Antisense Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Antisense Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Antisense Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Antisense Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.